213 related articles for article (PubMed ID: 7288622)
1. The disposition of acyclovir in different species.
de Miranda P; Krasny HC; Page DA; Elion GB
J Pharmacol Exp Ther; 1981 Nov; 219(2):309-15. PubMed ID: 7288622
[TBL] [Abstract][Full Text] [Related]
2. Species differences in the disposition of acyclovir.
de Miranda P; Krasny HC; Page DA; Elion GB
Am J Med; 1982 Jul; 73(1A):31-5. PubMed ID: 7102710
[TBL] [Abstract][Full Text] [Related]
3. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and bioavailability of acyclovir in the dog.
Krasny HC; de Miranda P; Blum MR; Elion GB
J Pharmacol Exp Ther; 1981 Feb; 216(2):281-8. PubMed ID: 7463350
[TBL] [Abstract][Full Text] [Related]
5. Physiological disposition and metabolic fate of a new antiarrhythmic agent, alpha, alpha-dimethyl-4-(alpha, alpha, beta, beta-tetrafluorophenethyl) benzylamine in the rat, dog, monkey, baboon, and man.
Zacchei AG; Weidner LL; Besselaar GH; Raftery EB
Drug Metab Dispos; 1976; 4(4):387-401. PubMed ID: 8295
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of mepindolol sulfate in the rat, dog, and rhesus monkey. Studies on species differences.
Krause W; Kühne G
Drug Metab Dispos; 1983; 11(2):91-6. PubMed ID: 6133729
[TBL] [Abstract][Full Text] [Related]
7. Physiological disposition and metabolism of cyclobenzaprine in the rat, dog, rhesus monkey, and man.
Hucker HB; Stauffer SC; Balletto AJ; White SD; Zacchei AG; Arison BH
Drug Metab Dispos; 1978; 6(6):659-72. PubMed ID: 33029
[TBL] [Abstract][Full Text] [Related]
8. Disposition of remoxipride in different species. Species differences in metabolism.
Widman M; Nilsson LB; Bryske B; Lundström J
Arzneimittelforschung; 1993 Mar; 43(3):287-97. PubMed ID: 8489555
[TBL] [Abstract][Full Text] [Related]
9. Disposition in the dog and the rat of 2, 6-diamino-9-(2-hydroxyethoxymethyl)purine (A134U), a potential prodrug of acyclovir.
Good SS; Krasny HC; Elion GB; de Miranda P
J Pharmacol Exp Ther; 1983 Dec; 227(3):644-51. PubMed ID: 6655561
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 2nd communication: distribution to organs and tissues in male, female and pregnant rats, and characteristics of protein binding in plasma.
Steinke W; Ahr HJ; Hirayama M
Arzneimittelforschung; 1997 Aug; 47(8):939-48. PubMed ID: 9296280
[TBL] [Abstract][Full Text] [Related]
11. Disposition and metabolism of fenbufen in several laboratory animals.
Chiccarelli FS; Eisner HJ; Van Lear GE
Arzneimittelforschung; 1980; 30(4A):707-15. PubMed ID: 6776965
[TBL] [Abstract][Full Text] [Related]
12. Physiological disposition of L-663,581, a partial agonist of the benzodiazepine receptor, in laboratory animals.
Chen IW; Lin JH
Drug Metab Dispos; 1994; 22(5):693-9. PubMed ID: 7835219
[TBL] [Abstract][Full Text] [Related]
13. Blood level, distribution, excretion, and metabolite pattern of [14C]-brotizolam in the rat, dog, and rhesus monkey.
Bechtel WD; Mierau J; Richter I; Stiasni M
Arzneimittelforschung; 1986 Mar; 36(3A):568-74. PubMed ID: 3718579
[TBL] [Abstract][Full Text] [Related]
14. Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs.
Kobayashi S; Sakai T; Dalrymple PD; Wood SG; Chasseaud LF
Arzneimittelforschung; 1993 Dec; 43(12):1367-77. PubMed ID: 8141830
[TBL] [Abstract][Full Text] [Related]
15. Comparative metabolism of fenclorac in rat, dog, monkey, and man.
DeLong AF; Smyth RD; Polk A; Nayak RK; Martin G; Douglas GH; Reavey-Cantiwell NH
Drug Metab Dispos; 1977; 5(2):122-31. PubMed ID: 15804
[TBL] [Abstract][Full Text] [Related]
16. Absorption and disposition of [14C]-molsidomine in laboratory animals.
Fromson JM; Illing HP; Ings RM; Johnson KI; Johnson P; Ostrowski J; Schraven E; Steward A
Arzneimittelforschung; 1981; 31(2):337-45. PubMed ID: 6894378
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of triclopyr (3,5,6-trichloro-2-pyridinyloxyacetic acid) in the beagle dog and rhesus monkey: perspective on the reduced capacity of dogs to excrete this organic acid relative to the rat, monkey, and human.
Timchalk C; Nolan RJ
Toxicol Appl Pharmacol; 1997 Jun; 144(2):268-78. PubMed ID: 9194410
[TBL] [Abstract][Full Text] [Related]
18. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
[TBL] [Abstract][Full Text] [Related]
19. Disposition and biotransformation of quinpirole, a new D-2 dopamine agonist antihypertensive agent, in mice, rats, dogs, and monkeys.
Whitaker NG; Lindstrom TD
Drug Metab Dispos; 1987; 15(1):107-13. PubMed ID: 2881745
[TBL] [Abstract][Full Text] [Related]
20. Metabolic fate of radioactive acyclovir in humans.
de Miranda P; Good SS; Krasny HC; Connor JD; Laskin OL; Lietman PS
Am J Med; 1982 Jul; 73(1A):215-20. PubMed ID: 7102704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
